The Modern Era of TAVR - Asymptomatic Aortic Stenosis and Beyond

Explore the latest developments in transcatheter aortic valve replacement (TAVR) technology and its expanding applications in this comprehensive cardiovascular grand rounds presentation. Learn about the evolving treatment paradigms for asymptomatic aortic stenosis, examining current evidence and clinical guidelines that are reshaping patient selection criteria. Discover how TAVR has transformed from a treatment option for high-risk patients to a viable intervention for intermediate and low-risk populations, including those with asymptomatic severe aortic stenosis. Examine the latest clinical trial data, procedural innovations, and long-term outcomes that are driving the expansion of TAVR indications. Understand the multidisciplinary heart team approach to patient evaluation, risk stratification methodologies, and shared decision-making processes in the modern TAVR era. Analyze comparative effectiveness data between TAVR and surgical aortic valve replacement across different patient populations and risk profiles. Review emerging technologies, valve designs, and procedural techniques that are improving patient outcomes and expanding treatment possibilities. Gain insights into future directions for TAVR therapy, including potential applications in younger patients, bicuspid aortic valve disease, and valve-in-valve procedures.